Table 2.
Vital Signs, Clinical Symptoms and Laboratory Parameters of PE Patients and Univariate Analysis According to Clinical Outcomes.
| Variable | Whole Group (N = 436) | In-Hospital Mortality (N = 38) | 90-day Mortality (N = 57) | Overall Mortality (N = 102) | Readmission (N = 146) |
|---|---|---|---|---|---|
| Vital signs | |||||
| Heart rate (BPM) (median IQR) | 95.00 (85.00-111.00) | 106.5 (93.00-118.00)† | 104.00 (89.00-114.00) | 100.50 (86.00-114.00) | 92.00 (82.00-105.00)* |
| Systolic blood pressure (mm Hg) (median IQR) | 116.50 (105.00-129.00) | 108.00 (94.00-125.00)† | 109.00 (96.00-120.00)† | 112.00 (99.00-128.00)* | 118.50 (106.00-131.00) |
| Respiratory rate (BMP) (median IQR) | 21.00 (18.00-25.00) | 24.00 (20.00-29.00)† | 22.00 (20.00-28.00)* | 22.00 (19.00-26.00) | 20.00 (18.00-24.00) |
| SaO2 (%) (median IQR) | 92.00 (90.00-94.00) | 91.50 (88.00-95.00)* | 92.00 (89.00-95.00) | 92.00 (88.00-94.00) | 92.00 (90.00-94.00) |
| Temperature (°C) (median IQR) | 36.8 (36.6-37.1) | 36.7 (36.4-36.9)* | 36.8 (36.6-36.9) | 36.7 (36.4-37.0)* | 36.8 (36.6-37.1) |
| Symptoms | |||||
| Hemoptysis, n (%) | 14 (3.2%) | 0 (0.0%) | 2 (3.5%) | 3 (2.9%) | 3 (2.1%) |
| Dyspnea, n (%) | 387 (88.8%) | 36 (94.7%) | 52 (91.2%) | 92 (90.2%) | 133 (91.1%) |
| Syncope, n (%) | 51 (11.17) | 8 (21.1%) | 9 (15.8%) | 14 (13.7%) | 13 (8.9%) |
| Chest pain, n (%) | 138 (31.7%) | 9 (23.7%) | 11 (19.3%)* | 18 (17.6%)‡ | 41 (28.1%) |
| Altered mental status, n (%) | 94 (21.6%) | 17 (44.7%)‡ | 22 (38.6%)‡ | 31 (30.4%)† | 24 (16.4%) |
| Lower limb DVT, n (%) | 216 (49.5%) | 14 (36.8%) | 24 (42.1%) | 46 (45.1%) | 76 (52.1%) |
| Laboratory parameters | |||||
| BUN (mg/dl) (median IQR) | 16.00 (11.00-23.00) | 25.00 (15.00-33.00)† | 24.00 (15.00-32.00)‡ | 22.00 (15.00-32.00)‡ | 16.00 (12.50-23.00) |
| Creatinine (mg/dl) (median IQR) | 0.98 (0.75-1.20) | 1.10 (0.82-1.63) | 1.04 (0.80-1.60) | 1.07 (0.86-1.48) | 0.99 (0.79-1.24) |
| D-dimer (ng/ml) (median IQR) | 5132.50 (1855.25-14516.00) | 9973.00 (2310.50-46313.50) | 5418.00 (2178.00-19959.00) | 4304.00 (1946.00-16312.00) | 5308.00 (2048.50-13875.50) |
| Troponin I (ng/ml) (median IQR) | 0.04 (0.03-0.17) | 0.11 (0.05 −0.72)‡ | 0.09 (0.04-0.22)‡ | 0.05 (0.03-0.14)* | 0.05 (0.03-0.17) |
| BNP (pg/ml) (median IQR) | 115.00 (45.75-380.25) | 448.00 (81.50-1105.00)‡ | 411.00 (106.00-1118.00)‡ | 279.00 (90.50-1051.00)‡ | 175.00 (67.00-357.00)† |
| Lactate (mmol/L) (median IQR) | 1.40 (1.10-2.10) | 2.50 (1.60-4.70)‡ | 2.00 (1.50-3.20)‡ | 2.00 (1.45-3.25)‡ | 1.50 (1.20-2.10) |
| Albumin (g/dl) (median IQR) | 3.30 (2.80-3.70) | 3.00 (2.50-3.40)‡ | 3.00 (2.50-3.40)‡ | 3.00 (2.50-3.40)‡ | 3.30 (2.90-3.50) |
Comparisons between patients with versus without clinical outcome. *P < .05; †P < .01; ‡P < .001.